These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 27720394)

  • 1. G Protein-coupled Receptor Kinase 2 (GRK2) Promotes Breast Tumorigenesis Through a HDAC6-Pin1 Axis.
    Nogués L; Reglero C; Rivas V; Salcedo A; Lafarga V; Neves M; Ramos P; Mendiola M; Berjón A; Stamatakis K; Zhou XZ; Lu KP; Hardisson D; Mayor F; Penela P
    EBioMedicine; 2016 Nov; 13():132-145. PubMed ID: 27720394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of GRK2 in cell signaling beyond GPCR desensitization: GRK2-HDAC6 interaction modulates cell spreading and motility.
    Penela P; Lafarga V; Tapia O; Rivas V; Nogués L; Lucas E; Vila-Bedmar R; Murga C; Mayor F
    Sci Signal; 2012 May; 5(224):pt3. PubMed ID: 22589388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interplay between G protein-coupled receptor kinase 2 (GRK2) and histone deacetylase 6 (HDAC6) at the crossroads of epithelial cell motility.
    Lafarga V; Mayor F; Penela P
    Cell Adh Migr; 2012; 6(6):495-501. PubMed ID: 23076141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pin1 Is Involved in HDAC6-mediated Cancer Cell Motility.
    Chuang HH; Huang MS; Wang PH; Liu YP; Hsiao M; Yang CJ
    Int J Med Sci; 2018; 15(13):1573-1581. PubMed ID: 30443180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-22 promotes epithelial cell transformation and breast tumorigenesis via MAP3K8 activation.
    Kim K; Kim G; Kim JY; Yun HJ; Lim SC; Choi HS
    Carcinogenesis; 2014 Jun; 35(6):1352-61. PubMed ID: 24517997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pin1 coordinates HDAC6 upregulation with cell migration in lung cancer cells.
    Chuang HH; Hsu JF; Chang HL; Wang PH; Wei PJ; Wu DW; Huang MS; Hsiao M; Yang CJ
    Int J Med Sci; 2020; 17(17):2635-2643. PubMed ID: 33162791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel GRK2/HDAC6 interaction modulates cell spreading and motility.
    Lafarga V; Aymerich I; Tapia O; Mayor F; Penela P
    EMBO J; 2012 Feb; 31(4):856-69. PubMed ID: 22193721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prolyl isomerase Pin1 enhances HER-2 expression and cellular transformation via its interaction with mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1.
    Khanal P; Namgoong GM; Kang BS; Woo ER; Choi HS
    Mol Cancer Ther; 2010 Mar; 9(3):606-16. PubMed ID: 20179161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cytoplasmic deacetylase HDAC6 is required for efficient oncogenic tumorigenesis.
    Lee YS; Lim KH; Guo X; Kawaguchi Y; Gao Y; Barrientos T; Ordentlich P; Wang XF; Counter CM; Yao TP
    Cancer Res; 2008 Sep; 68(18):7561-9. PubMed ID: 18794144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells.
    Khanal P; Yun HJ; Lim SC; Ahn SG; Yoon HE; Kang KW; Hong R; Choi HS
    Oncogene; 2012 Aug; 31(34):3845-56. PubMed ID: 22158035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolyl isomerase Pin1 negatively regulates the stability of SUV39H1 to promote tumorigenesis in breast cancer.
    Khanal P; Kim G; Lim SC; Yun HJ; Lee KY; Choi HK; Choi HS
    FASEB J; 2013 Nov; 27(11):4606-18. PubMed ID: 23934277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhein exhibits antitumorigenic effects by interfering with the interaction between prolyl isomerase Pin1 and c-Jun.
    Cho JH; Chae JI; Shim JH
    Oncol Rep; 2017 Mar; 37(3):1865-1872. PubMed ID: 28184937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COT phosphorylates prolyl-isomerase Pin1 to promote tumorigenesis in breast cancer.
    Kim G; Khanal P; Kim JY; Yun HJ; Lim SC; Shim JH; Choi HS
    Mol Carcinog; 2015 Jun; 54(6):440-8. PubMed ID: 24265246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SUPT5H Post-Transcriptional Silencing Modulates PIN1 Expression, Inhibits Tumorigenicity, and Induces Apoptosis of Human Breast Cancer Cells.
    Lone BA; Ahmad F; Karna SKL; Pokharel YR
    Cell Physiol Biochem; 2020 Sep; 54(5):928-946. PubMed ID: 32961044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional interaction of histone deacetylase 5 (HDAC5) and lysine-specific demethylase 1 (LSD1) promotes breast cancer progression.
    Cao C; Vasilatos SN; Bhargava R; Fine JL; Oesterreich S; Davidson NE; Huang Y
    Oncogene; 2017 Jan; 36(1):133-145. PubMed ID: 27212032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of PTOV1 and PIN1 exhibit common phenotypic anti-cancer effects in MDA-MB-231 cells.
    Karna SKL; Ahmad F; Lone BA; Pokharel YR
    PLoS One; 2019; 14(5):e0211658. PubMed ID: 31083670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis.
    Wulf G; Garg P; Liou YC; Iglehart D; Lu KP
    EMBO J; 2004 Aug; 23(16):3397-407. PubMed ID: 15257284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation and Stabilization of PIN1 by JNK Promote Intrahepatic Cholangiocarcinoma Growth.
    Lepore A; Choy PM; Lee NCW; Carella MA; Favicchio R; Briones-Orta MA; Glaser SS; Alpini G; D'Santos C; Tooze RM; Lorger M; Syn WK; Papakyriakou A; Giamas G; Bubici C; Papa S
    Hepatology; 2021 Nov; 74(5):2561-2579. PubMed ID: 34048060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptidyl-prolyl cis/trans isomerase NIMA-interacting 1 as a molecular target in breast cancer: a therapeutic perspective of gynecological cancer.
    Kim G; Bhattarai PY; Choi HS
    Arch Pharm Res; 2019 Feb; 42(2):128-139. PubMed ID: 30684192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptidyl-prolyl cis/trans isomerase Pin1 regulates withaferin A-mediated cell cycle arrest in human breast cancer cells.
    Samanta SK; Lee J; Hahm ER; Singh SV
    Mol Carcinog; 2018 Jul; 57(7):936-946. PubMed ID: 29603395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.